
Key findings from life sciences digital pathology adoption survey
Nearly three-fourths of life sciences organisations surveyed have invested in digital pathology to advance drug research and development (R&D), according to new research commissioned by Proscia. Over half of these organisations (53%) still center their operations around legacy software systems primarily for basic image viewing despite growing adoption of… Read More






